About 50% of total direct cost of Type 2 Diabetes in South Africa attributed to related complications of the disease
A recent study examined the direct medical costs of type 2 diabetes mellitus (T2DM) in the public health sector in South Africa for the year 2018. The research also postulated the projected costs of the chronic illness for the year 2030. Diagnostic, disease management, and T2DM-linked co-morbidity costs were enumerated.
The results showed that in 2018, the direct cost of T2DM in the public sector exceeded ZAR 2.7 billion (USD 198 million), based on 240,000 diagnosed cases. About 49% of the total direct cost was attributed to complications and the remainder to treatment and management. One third of the total direct cost was attributed to medication. If the cost of undiagnosed diabetes were included, the total annual expenditure would increase by close to 9 times, costing ZAR 19.1 billion. The projected cost of T2DM in 2030 is ZAR 35.1 billion (USD 2.5 billion). For further details, read the entire study here.